603077:SSESichuan Hebang Biotechnology Co. Ltd. Class A Analysis
Data as of 2026-09-04 - not real-time
CN¥2.30
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Sichuan Hebang Biotechnology Corporation Limited is priced at ¥2.30, and its moving averages give no clean directional read — the structure is neutral. RSI sits at 43.0, which reads as neutral, and MACD momentum is bearish. Recent trading has carved out support near ¥2.29 and resistance around ¥2.52.
Multiples put this in fair territory at a P/E of 3.4. Revenue is contracting at 31.7% on a -3.4% profit margin.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 29.4%, a beta of 0.41 and a maximum drawdown of 37.5%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons line up on sell — conviction 4 out of 10.
Multiples put this in fair territory at a P/E of 3.4. Revenue is contracting at 31.7% on a -3.4% profit margin.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 29.4%, a beta of 0.41 and a maximum drawdown of 37.5%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons line up on sell — conviction 4 out of 10.
Top Market Events
Get the latest Sichuan Hebang Biotechnology Corporation Limited 603077.Yahoo Finance1ySichuan Hebang Biotechnology Corporation Limited 603077.Yahoo Finance1ySichuan Hebang Biotechnology Corporation Limited 603077.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Trading below the 200-day average of 2.51
- MACD momentum is negative
- Maximum drawdown of 37.5%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Trading below the 200-day average of 2.51
- MACD momentum is negative
- P/E ratio of 3.4
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Negative profit margin of -3.4%
- Negative return on equity of -2.0%
- Revenue contracting at -31.7%
Key Metrics & Analysis
Financial Health
Revenue Growth-31.70%
Profit Margin-3.38%
P/E Ratio3.4
ROE-1.99%
ROA0.63%
Debt/Equity45.63
P/B Ratio1.0
Op. Cash FlowCN¥1.1B
Free Cash FlowCN¥-238361200
Technical Analysis
TrendNeutral
RSI43.0
SupportCN¥2.29
ResistanceCN¥2.52
MA 20CN¥2.39
MA 50CN¥2.34
MA 200CN¥2.51
MACDBearish
VolumeIncreasing
Fear & Greed Index96
Valuation
Fair ValueCN¥0.94
GradeFair
TypeValue
Risk Assessment
Beta0.41
Volatility29.38%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.